Skip to main content
logo
CU Medical Systems, Inc. (KOSDAQ:115480)
South Korea flag South Korea · Delayed Price · Currency is KRW
1,783.00
+78.00 (4.57%)
At close: Jul 31, 2026

CU Medical Systems Cash Flow Statement

Millions KRW. Fiscal year is Jan - Dec.

Operating Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Net Income
3,185819.2-3,204-8,2049,425-13,981
Depreciation & Amortization
3,4073,2932,6581,9351,6511,945
Loss (Gain) From Sale of Assets
0-3.5-8.7-119.88-861.7710.49
Asset Writedown & Restructuring Costs
--1,0552,781370.575,267
Loss (Gain) From Sale of Investments
8,2978,5859,2149,6371,0248,046
Provision & Write-off of Bad Debts
109.4929.58-875.721,701-154.21-389.72
Other Operating Activities
1,7261,9121,215474.152,4018,068
Change in Accounts Receivable
-1,160-3,820-641.81-2,005-4,348-2,165
Change in Inventory
-2,335-715.392,9661,358-4,887-834.41
Change in Accounts Payable
168.52-705.14-11.97857.79358.8956.05
Change in Unearned Revenue
253.05147.4-11.5-64.26-524.64
Change in Other Net Operating Assets
-293.32144.751,717-139.69-1,923-5,906
Operating Cash Flow
13,3569,68714,0728,2753,121490.43
Operating Cash Flow Growth
-11.05%-31.16%70.06%165.11%536.46%-94.17%

Investing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Capital Expenditures
-1,049-1,058-20,056-6,382-11,586-5,186
Sale of Property, Plant & Equipment
21.973.529.8431.36-24.45
Cash Acquisitions
-19,839-440.23----
Divestitures
---10--
Sale (Purchase) of Intangibles
-235.77-235.77-6.5-89.14-18.6349.65
Investment in Securities
7,7874,378-11,577-4,783-5,6522,735
Other Investing Activities
-1,857-3,131-260.16-308.622,737231.97
Investing Cash Flow
-15,392-537.62-31,870-11,476-13,969-1,518

Financing Activities

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Short-Term Debt Issued
--2,0501,0008.1811,102
Long-Term Debt Issued
--30,0006,69410,6205,480
Total Debt Issued
15,800-32,0507,69410,62816,582
Short-Term Debt Repaid
--2,346-1,000--1,221-14,130
Long-Term Debt Repaid
--1,873-18,628-656.28-4,480-11,222
Total Debt Repaid
-2,962-4,219-19,628-656.28-5,701-25,352
Net Debt Issued (Repaid)
12,838-4,21912,4227,0374,927-8,770
Issuance of Common Stock
--8,009-373.319,009
Repurchase of Common Stock
-769.33--71.24---
Other Financing Activities
-260-724.37-0--
Financing Cash Flow
11,809-4,21921,0857,0375,30010,239

Net Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Foreign Exchange Rate Adjustments
-51.55103.25363.21-70.4-191.36-12.01
Miscellaneous Cash Flow Adjustments
------365.2
Net Cash Flow
9,7215,0343,6503,766-5,7398,834

Free Cash Flow

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Free Cash Flow
12,3088,629-5,9841,893-8,465-4,696
Free Cash Flow Growth
------
Free Cash Flow Margin
22.52%17.89%-14.73%4.53%-18.03%-13.26%
Free Cash Flow Per Share
964.43712.86-588.26197.93-937.51-692.09
Levered Free Cash Flow
-1,7055,352-9,027-4,94411,830686.73
Unlevered Free Cash Flow
-800.066,255-8,310-4,74112,1141,397

Additional Metrics

Fiscal Year
TTMFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Mar '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Cash Interest Paid
1,3921,4131,078288.48329.48637.64
Cash Income Tax Paid
521.6469.48277.371,377347.03398.71
Change in Working Capital
-3,367-4,9484,01870.62-10,734-8,474